Involvement of TLR2 in innate response to Bacillus anthracis infection

Innate Immunity

Volumn 15, Issue 1, 2009, Pages 43-51

  Weiss, Shay ^a,b   Levy, Haim ^a   Fisher, Morly ^a   Kobiler, David ^a   Altboum, Zeev ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^b NONE   (Israel)

Author keywords

Bacillus anthracis; Innate immunity; TLR2; TNF

Indexed keywords

TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL INFECTION; BACTERIAL SPORE; BACTERIAL STRAIN; CHINESE HAMSTER; CONTROLLED STUDY; CYTOKINE RELEASE; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INFECTION SENSITIVITY; INNATE IMMUNITY; INOCULATION; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PHAGOCYTOSIS; SYRIAN HAMSTER;

ANIMALS; ANTHRAX; BACILLUS ANTHRACIS; CELL LINE; CRICETINAE; CRICETULUS; CYTOKINES; IMMUNITY, INNATE; MACROPHAGES; MESOCRICETUS; MICE; PHAGOCYTOSIS; SPORES, BACTERIAL; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); CRICETINAE; CRICETULUS GRISEUS; MESOCRICETUS AURATUS; MURINAE;

EID: 59749092501     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425908100379     Document Type: Article

References (33)

1. Jernigan DB, Raghunathan PL, Bell BP et al. Investigation of bioterrorism-related anthrax, United States, 2001: Epidemiologic findings. Emerg Infect Dis 2002; 8: 1019-1028.
2. Jernigan JA, Stephens DS, Ashford DA et al. Industry-related outbreak of human anthrax. Emerg Infect Dis 2003; 9: 1657-1659.
3. Guidi-Rontani C., Weber-Levy M., Labruyere E. et al. Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol 1999; 31: 9-17.
4. Guidi-Rontani C. The alveolar macrophage: The Trojan horse of Bacillus anthracis. Trends Microbiol 2002; 1: 405-409.
5. Dixon TC, Fadl AA, Koehler TM et al. Early Bacillus anthracis- macrophage interactions: Intracellular survival and escape. Cell Microbiol 2000; 2: 453-463.
6. Kang TJ, Fenton MJ, Weiner MA et al. Murine macrophages kill the vegetative form of Bacillus anthracis. Infect Immun 2005; 73: 7495-7501.
7. Welkos S., Friedlander A., Weeks S. et al. In vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J Med Microbiol 2002; 51: 821-831.
8. Mourez M. Anthrax toxins. Rev Physiol Biochem Pharmacol 2004; 152: 135-164.
9. Guidi-Rontani C., Mock M. Macrophage interactions. Curr Top Microbiol Immunol 2002; 271: 115-141.
10. Dixon TC, Meseslson M., Guilemin J. et al. Anthrax. N Engl J Med 1999; 341: 815-826.
11. Welkos SL, Keener TJ, Gibbs PH Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun 1986; 51: 795-800.
12. Tournier JN, Quesnel-Hellmann A., Mathieu J. et al. Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol 2005; 174: 4934-4941.
13. Ezzell JW, Welkos SL The capsule of Bacillus anthracis, a review. J Appl Microbiol 1999; 87: 250.
14. Pickering AK, Merkel TJ Macrophages release tumor necrosis factor alpha and interleukin-12 in response to intracellular Bacillus anthracis spores. Infect Immun 2004; 72: 3069-3072.
15. Pickering AK, Osorio M., Lee GM et al. Cytokine response to infection with Bacillus anthracis spores. Infect Immun 2004; 72: 6382-6389.
16. Cleret A., Ouesnel-Hellmann A., Mathieu J. et al. Resident CD11c+ lung cells are impaired by anthrax toxins after spore infection. J Infect Dis 2006; 194: 86-94.
17. Chakrabarty K., Wu W., Booth JL et al. Bacillus anthracis spores stimulate cytokine and chemokine innate immune responses in human alveolar macrophages through multiple mitogen-activated protein kinase pathways. Infect Immun 2006; 74: 4430-4438.
18. Kaisho T., Akira S. Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 2002; 1589: 1-13.
19. Levy H., Fisher M., Ariel N. et al. Identification of strain specific markers in Bacillus anthracis by random amplification of polymorphic DNA. FEMS Microbiol Lett 2005; 244: 199-205.
20. Reed L., Muench H. A simple method of estimating fifty percent end points. Am J Hygiene 1938; 27: 493-497.
21. Altboum Z., Gozes Y., Barnea A. et al. Postexposure prophylaxis against anthrax: Evaluation of various treatment regimens in intranasally infected guinea pigs. Infect Immun 2002; 70: 6231-6241.
22. Tamir H., Gilvar C. Density gradient centrifugation for separation of sporulating forms of bacteria. J Biol Chem 1966; 241: 1085-1090.
23. Gat O., Mendelson I., Chitlaru T. et al. The solute-binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinant. Mol Microbiol 2005; 58: 533-551.
24. Hanby WE, Rydon HN The capsular substance of Bacillus anthracis. Biochem J 1946; 40: 297-309.
25. Chen AR, McKinnon KP, Koren HS Lipopolysaccharide stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor. J Immunol 1985; 135: 3978-3987.
26. Kobiler D., Weiss S., Levy H. et al. Protective antigen as a correlative marker for anthrax in animal models. Infect Immun 2006; 74: 5871-5876.
27. Hanna PC, Ireland JA Understanding Bacillus anthracis pathogenesis. Trends Microbiol 1999; 7: 180-182.
28. Nicholson WL, Galeano B. UV resistance of Bacillus anthracis revisited: validation of Bacillus subtilis spores as UV surrogates for spores of Bacillus anthracis. Appl Environ Microbiol 2003; 69: 1327-1330.
29. Heine H., Kirschning CJ, Lien E. et al. Cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin. J Immunol 1999; 162: 6971-6975.
30. Henneke P., Takeuchi O., van-Strijp JA et al. Novel engagement of CD14 and multiple Toll-like receptors by group B streptococci. J Immunol 2001; 167: 7069-7076.
31. Hughes MA, Green CS, Lowchyj L. et al. MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of mice: Implications for Toll-like receptor signaling. Infect Immun 2005; 73: 7535-7540.
32. Kim SO, Jing Q., Hoebe K. et al. Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-alpha. J Biol Chem 2003; 278: 7413-7421.
33. Fellows PF, Liscott MK, Little SF et al. Anthrax vaccine efficacy in golden Syrian hamsters. Vaccine 2002; 20: 1421-1424.